# FDA Inspection 1310680 - BioLife Plasma Services LP - March 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/67cec22d-a06e-4d5e-9db0-60ef17d5d180
Source feed: FDA_Inspections

> FDA Inspection 1310680 for BioLife Plasma Services LP on March 27, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1310680
- Company Name: BioLife Plasma Services LP
- Inspection Date: 2026-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1315930 - 2026-05-04](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/8d9bc5f7-5628-483c-af3f-5bcb2e8ef592)
- [FDA Inspection 1315386 - 2026-04-14](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/2d653525-38d6-489a-a115-3935437df73c)
- [FDA Inspection 1304742 - 2026-02-23](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/67c44fc5-8794-4dbf-9f7e-4e4ec3d9624d)
- [FDA Inspection 1297342 - 2025-12-18](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/701dfdf7-587b-4de7-8f5f-00ef3a4abc38)
- [FDA Inspection 1297750 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/876cedad-7bd3-474b-ba6b-712922e3ebe2)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/897c1d39-fa52-45d4-b7aa-dd146352b02c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d